COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation

被引：0
|
作者：
Fumiaki Sato
Atsunobu Sagara
Kaede Tajima
Shotaro Miura
Kenjiro Inaba
Yusuke Ando
Teruaki Oku
Takashi Murakami
Yoshinori Kato
Tetsuro Yumoto
机构：
[1] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Laboratory of Analytical Pathophysiology
[2] Josai University,Laboratory of Clinical Pathology, Faculty of Pharmacy
[3] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Department of Microbiology
[4] Saitama Medical University,Department of Microbiology, Faculty of Medicine
[5] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Laboratory of Biopharmaceutics and Analytical Science
来源：
Breast Cancer Research and Treatment | 2022年 / 194卷
关键词：
COL8A1; Triple-negative breast cancer; Hypoxia; Focal adhesion kinase; Tumor growth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：243 / 256
页数：13
相关论文
共 50 条
  • [1] COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation
    Sato, Fumiaki
    Sagara, Atsunobu
    Tajima, Kaede
    Miura, Shotaro
    Inaba, Kenjiro
    Ando, Yusuke
    Oku, Teruaki
    Murakami, Takashi
    Kato, Yoshinori
    Yumoto, Tetsuro
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 243 - 256
  • [2] Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling
    Lee, Eunkyung
    Choi, Ahyoung
    Jun, Yukyung
    Kim, Namhee
    Yook, Jong In
    Kim, Soo Youl
    Lee, Sanghyuk
    Kang, Sang Won
    REDOX BIOLOGY, 2020, 29
  • [3] Src: a potential target for the treatment of triple-negative breast cancer
    Tryfonopoulos, D.
    Walsh, S.
    Collins, D. M.
    Flanagan, L.
    Quinn, C.
    Corkery, B.
    McDermott, E. W.
    Evoy, D.
    Pierce, A.
    O'Donovan, N.
    Crown, J.
    Duffy, M. J.
    ANNALS OF ONCOLOGY, 2011, 22 (10) : 2234 - 2240
  • [4] DLAT promotes triple-negative breast cancer progression via YAP1 activation
    Liu, Diya
    Wang, Xuehui
    Qian, Fengyuan
    Ye, Danrong
    Deng, Xiaochong
    Fang, Lin
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [5] FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer
    Pan, Mei-Ren
    Hou, Ming-Feng
    Ou-Yang, Fu
    Wu, Chun-Chieh
    Chang, Shu-Jyuan
    Hung, Wen-Chun
    Yip, Hon-Kan
    Luo, Chi-Wen
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (01)
  • [6] Partial agonistic effect of cetuximab on epidermal growth factor receptor and Src kinase activation in triple-negative breast cancer cell lines
    Gurdal, Hakan
    Tuglu, Matilda Merve
    Bostanabad, Saber Yari
    Dalkilic, Basak
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (04) : 1345 - 1356
  • [7] Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer
    Pan, Mei-Ren
    Wu, Cheng-Che
    Kan, Jung-Yu
    Li, Qiao-Lin
    Chang, Shu-Jyuan
    Wu, Chun-Chieh
    Li, Chung-Liang
    Ou-Yang, Fu
    Hou, Ming-Feng
    Yip, Hon-Kan
    Luo, Chi-Wen
    CANCERS, 2020, 12 (01)
  • [8] D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1
    Zhang, Ruonan
    Yang, Yajing
    Dong, Wenjing
    Lin, Mingen
    He, Jing
    Zhang, Xinchao
    Tian, Tongguan
    Yang, Yunlong
    Chen, Kun
    Lei, Qun-Ying
    Zhang, Song
    Xu, Yanping
    Lv, Lei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (08)
  • [9] Efp promotes growth of triple-negative breast cancer cells
    Sato, Wataru
    Ikeda, Kazuhiro
    Gotoh, Noriko
    Inoue, Satoshi
    Horie, Kuniko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 624 : 81 - 88
  • [10] EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer
    Li, Zishuo
    Liu, Qiao
    Cai, Yuhao
    Ye, Na
    He, Zinan
    Yao, Yuying
    Ding, Yi
    Wang, Pingyuan
    Qi, Cuiling
    Zheng, Lingyun
    Wang, Lijing
    Zhou, Jia
    Zhang, Qian -Qian
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (04):
12345